Skip to content
ReportWire

Breaking News & Top Current Stories – Latest US News and News from Around the World

Tag: new product

Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study

Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study

December 4, 2023December 4, 2023 · Breaking News

By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The Swiss pharmaceutical company said Tuesday…

Read more Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study
Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study

Novartis Says Kidney Drug Phase 3 Trial Reaches Positive Interim Result

October 1, 2023October 2, 2023 · Breaking News

By Adria Calatayud Novartis said an interim analysis from a phase 3 trial to evaluate its investigational iptacopan drug in patients with kidney disease nephropathy achieved positive results,…

Read more Novartis Says Kidney Drug Phase 3 Trial Reaches Positive Interim Result
Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study

Roche Lung Cancer Drug Shows Promise in Phase 3 Trial

August 31, 2023September 1, 2023 · Breaking News

By David Sachs Roche said Friday that its Alecensa drug demonstrated the ability to reduce recurrence of lung cancer for patients in the early stage of the disease.…

Read more Roche Lung Cancer Drug Shows Promise in Phase 3 Trial
Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study

BioVie Shares jump Premarket on Parkinson’s, Alzheimer’s Studies >BIVI

December 6, 2022December 6, 2022 · Breaking News

By Colin Kellaher Shares of BioVie Inc. rose sharply in premarket trading Tuesday after the clinical-stage biopharmaceutical company reported positive results from a pair of Phase 2 studies…

Read more BioVie Shares jump Premarket on Parkinson’s, Alzheimer’s Studies >BIVI
Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study

GSK Says Dreamm-3 Phase 3 Study For Blenrep Didn’t Meet Primary Endpoint

November 7, 2022November 7, 2022 · Breaking News

By Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients with relapsed or refractory multiple myeloma didn’t meet its primary endpoint of progression-free…

Read more GSK Says Dreamm-3 Phase 3 Study For Blenrep Didn’t Meet Primary Endpoint
Moderna Stock Takes Off on Cancer Vaccine News

Moderna Stock Takes Off on Cancer Vaccine News

October 12, 2022October 12, 2022 · Business

Moderna stock shot up after Merck said it is exercising an option to work on a personalized cancer vaccine with the Covid-19 vaccine maker. Merck (ticker: MRK) will…

Read more Moderna Stock Takes Off on Cancer Vaccine News
Smart City Projects Are Not Only Big City Projects: RealTerm Energy Launches MyTown, a New Smart City Solution Designed Specifically for Small and Medium-Sized Municipalities

Smart City Projects Are Not Only Big City Projects: RealTerm Energy Launches MyTown, a New Smart City Solution Designed Specifically for Small and Medium-Sized Municipalities

April 16, 2019January 28, 2023 · Government

Press Release – updated: Apr 16, 2019 ANNAPOLIS, Md., April 16, 2019 (Newswire.com) – ​​RealTerm Energy launches MyTown, a new smart city app and asset management platform, made…

Read more Smart City Projects Are Not Only Big City Projects: RealTerm Energy Launches MyTown, a New Smart City Solution Designed Specifically for Small and Medium-Sized Municipalities
Chicago Comb Company Receives 2 Design Patents for Metal Combs

Chicago Comb Company Receives 2 Design Patents for Metal Combs

May 9, 2017November 6, 2022 · Lifestyle

The award-winning Chicago Comb Company has been granted one of the most distinguished awards for their products. They have been issued two design patents for their unique combs…

Read more Chicago Comb Company Receives 2 Design Patents for Metal Combs
© 2026 . All rights reserved.